Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricONCBeOne Medicines AGBIIBBiogenMRNAModerna
Snapshot
Price$354.45$220.54$188.54
Market cap$33.43B$31.91B$31.65B
Valuation
P/E71.9x23.7x—
Forward P/E—25.8x—
Growth
Revenue growth36.2%1.2%-30.0%
EPS growth—-8.1%—
Profitability
Net margin7.8%13.8%-143.6%
ROE5.2%7.5%-36.7%
Balance sheet & cash
Debt / equity0.25x0.34x0.07x
Free cash flow yield—6.8%-13.6%
Dividend yield———
Verdict
Investment ratingNeutral· 48Neutral· 49Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearONCtoday $354BIIBtoday $221MRNAtoday $189
2027$362.02 – $530.96+50% CAGR$168.71 – $247.45+12% CAGR$144.23 – $211.54+12% CAGR
2028$493.00 – $723.06+43% CAGR$172.09 – $252.39+7% CAGR$147.12 – $215.77+7% CAGR
2029$671.36 – $984.66+41% CAGR$175.53 – $257.44+5% CAGR$150.06 – $220.09+5% CAGR
2030$914.26 – $1,340.91+39% CAGR$179.04 – $262.59+4% CAGR$153.06 – $224.49+4% CAGR
2031$1,245.04 – $1,826.06+39% CAGR$182.62 – $267.84+4% CAGR$156.12 – $228.98+4% CAGR
5-yr CAGR28.6% – 38.8%-3.7% – 4.0%-3.7% – 4.0%